Genfit S.A.

€10.60As of Sun 8 Nov 2026, 12:00 UTC
EPA:GNFTHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (4.63%)
Div yield —
ROE (5189.63%)
Biotechnology
Beta (5Y) 1.20
PE TTM —
TSR TTM 192.98%
Mkt cap €530.3M
ROIC (96.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€13
19.91%
(69.11%)
Hold 1|4|1|5|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.13
0.14
0.15
0.15
10.75%
23.60%
21.04%
14.64%
Revenue€M
36.62
36.68
37.48
36.42
(4.98%)
(5.59%)
(2.72%)
(2.91%)
Peers (US$595.5M)
Cap (US$)
PE
902.0M
—
534.5M
—
596.2M
31.61x
Capital
TTM
5Y
10Y
Leveragex
1.102
(0.231)
(0.203)
EBIT/Intx
0.332
0.071
0.070
Own earn%
(35.09)
(99.28)
(95.41)
Sh yield%
41.62
67.73
66.03
Owners
Insiders/Inst%
4.96
79.04
Short interest%
2.16
SBC / revenue%
2.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
15–21
$1 testx
0.0
Incr. ROIC%
1